CD274 and ovarian carcinoma: Interruption of PD-1/PD-L1 ligation via CRISPR-mediated deletion of PD-L1 on ovarian cancer significantly improved the efficacy of adoptively transferred second-generation CAR-T cells in preclinical models (Yeku et al., 2017).